@lasoso007's body image concerns after Wegovy, fact-checked
Quick answer
The creator describes an inability to perceive significant body changes after major weight loss, likely accelerated by semaglutide (Wegovy). This aligns with documented delays in cognitive body image updating following rapid or substantial weight loss, a phenomenon observed in both pharmacological and surgical weight-loss populations. Clinical guidelines for GLP-1 therapy do not currently mandate psychological screening for body image disturbance, though emerging research suggests this gap in care is meaningful.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @lasoso007 actually say?
Honestly, this is a tough one to fact-check. The transcript is largely incoherent, possibly the result of auto-captioning a French-language video. What we can piece together from the caption is the actual claim: after significant weight loss, the creator says she cannot perceive the changes in her own body, and she's asking followers whether they experience the same thing. That's a real, documented psychological phenomenon, and it deserves a serious look.
The hashtags mention Wegovy, weight loss, liposuction, and opinion. So we're likely looking at someone who has lost substantial weight, possibly with semaglutide, and is describing a disconnect between their physical reality and their self-perception. That's the claim we're fact-checking.
Does the science back this up?
Yes, and more robustly than most TikTok health content deserves. The psychological lag between physical transformation and body image adjustment is well-documented, particularly in post-bariatric and rapid weight-loss populations.
A 2012 study by Jumbe et al. in Clinical Obesity found that body image dissatisfaction often persists even after significant weight loss, with patients continuing to perceive themselves as larger than they are. More recently, research published by Conceição et al. (2017, Obesity Reviews) identified that cognitive body image, meaning how you mentally represent your own body, updates far more slowly than the body itself changes. This is sometimes called "phantom fat" or weight-loss body dysmorphia in clinical shorthand, though neither term is a formal DSM diagnosis.
With GLP-1 medications like semaglutide producing weight losses of 15 to 20 percent of body weight in trials (Wilding et al., 2021, New England Journal of Medicine), the gap between how patients look and how they feel they look can be significant. The brain's internal body map, called the body schema, simply hasn't caught up.
What did they get wrong (or right)?
To be fair, the creator didn't make any specific medical claims here, so there's not much to correct on the facts. She's describing a personal experience and asking a community question. That's fine, and arguably responsible compared to the average GLP-1 content on TikTok.
What's missing, and this matters, is any acknowledgment that this psychological experience can tip into something clinically significant. Body dysmorphic disorder (BDD) affects an estimated 2 to 3 percent of the general population (Veale, 2004, Advances in Psychiatric Treatment), and people who have experienced obesity or rapid weight change are at elevated risk. There's a real difference between "I'm still adjusting to how I look" and a persistent, distressing preoccupation that interferes with daily functioning.
The liposuction hashtag is also worth flagging. Research consistently shows that surgical body contouring after major weight loss does not reliably resolve body image dissatisfaction unless combined with psychological support (Monstrey et al., 2018, Plastic and Reconstructive Surgery). That's something anyone considering that route should know upfront.
What should you actually know?
If you've lost significant weight, on Wegovy or otherwise, and you still see your old body in the mirror, you are not imagining it and you are not alone. The phenomenon is real, it has a neurological basis, and it usually resolves with time. But "usually" is not "always."
A few things worth knowing: psychological counseling, particularly cognitive behavioral therapy adapted for body image, has the strongest evidence base for helping this adjustment process (Cash, 2012, Body Image). Seeking surgery to fix a perception problem before addressing the perception itself often doesn't work. And if the distress is severe, meaning it occupies hours of your day or prevents you from leaving the house, that warrants a clinical conversation, not just a TikTok comment section.
GLP-1 medications are effective tools for weight loss, but the mental health component of major body change is consistently under-discussed in patient education. Platforms prescribing semaglutide should be building psychological support into the care pathway, not leaving patients to process it via social media.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Compounded Semaglutide access requires the right clinical path
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 8 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @lasoso007's body image concerns after Wegovy, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Primary STEP 1 trial source for semaglutide weight-management efficacy and adverse-event context.
PubMed
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance
Used for maintenance, discontinuation, and weight-regain discussions after semaglutide response.
PubMed
Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference
A broad meta-analysis anchor for GLP-1 weight-loss effect and class-level comparisons.
PubMed
Discontinuing glucagon-like peptide-1 receptor agonists and body habitus
Used for pages discussing stopping therapy, weight regain, and long-term planning.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Compounded Semaglutide is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this semaglutide video claims cluster
Best for searchers comparing social semaglutide claims with GLP-1 eligibility, outcomes, and safety context.
Claim verdict
The useful answer behind this video
Claim being checked
The creator describes an inability to perceive significant body changes after major weight loss, likely accelerated by semaglutide (Wegovy).
FormBlends verdict
The creator describes an inability to perceive significant body changes after major weight loss, likely accelerated by semaglutide (Wegovy). This aligns with documented delays in cognitive body image updating following rapid or substantial weight loss, a phenomenon observed in both pharmacological and surgical weight-loss populations. Clinical guidelines for GLP-1 therapy do not currently mandate psychological screening for body image disturbance, though emerging research suggests this gap in care is meaningful.
Patient-safe next step
Compare the claim with the Compounded Semaglutide guide, safety notes, access rules, and a licensed-provider review.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The creator describes an inability to perceive significant body changes after major weight loss, likely accelerated by semaglutide (Wegovy). This aligns with documented delays in cognitive body image updating following rapid or substantial weight loss, a phenomenon observed in both pharmacological and surgical weight-loss populations. Clinical guidelines for GLP-1 therapy do not currently mandate psychological screening for body image disturbance, though emerging research suggests this gap in care is meaningful.
- Wilding et al. (2021, NEJM) showed semaglutide produces average weight loss of around 15 percent of body weight, a change large enough to create a significant gap between physical reality and self-perception.
- The brain's body schema, its internal map of your size and shape, updates more slowly than the body itself changes, which is why the disconnect feels real even when it isn't accurate.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compounded Semaglutide decisions still need source quality, legal access, and provider oversight checks.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against the Compounded Semaglutide guide, cost path, safety notes, and provider review before acting.
Review Compounded SemaglutideWhat You'll Learn
- Wilding et al. (2021, NEJM) showed semaglutide produces average weight loss of around 15 percent of body weight, a change large enough to create a significant gap between physical reality and self-perception.
- The brain's body schema, its internal map of your size and shape, updates more slowly than the body itself changes, which is why the disconnect feels real even when it isn't accurate.
- Jumbe et al. (2012, Clinical Obesity) found body image dissatisfaction commonly persists after significant weight loss, independent of how much weight was lost.
- Body dysmorphic disorder affects an estimated 2 to 3 percent of the general population (Veale, 2004, Advances in Psychiatric Treatment), and people with a history of obesity or rapid weight change are at elevated risk.
- Cognitive behavioral therapy targeting body image has the strongest evidence base for resolving post-weight-loss perceptual distortions. Cash (2012, Body Image) outlines structured approaches used in clinical practice.
- Surgical contouring before addressing underlying body image perception problems often fails to produce the satisfaction patients expect. Psychological readiness should be assessed before pursuing liposuction or skin removal surgery.
- Current GLP-1 prescribing guidelines do not require psychological screening for body image disturbance, a gap that clinicians and regulated telehealth platforms should be actively working to close.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
La soso · TikTok creator
10.9K views on this video
C’est un sujet … pas super facile. Après une grosse perte de poids est ce que vous vous rendez compte que votre corps a changé ? Je n’y arrive pas et j’ai besoin d’avoir votre avis. #wegovy #pertedepo
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by La soso, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.